Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 26 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Stage IB Cervical Cancer FIGO 2018 1 Spondylitis, Ankylosing 1 Psoriasis 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Melanoma 1 Lupus Erythematosus, Systemic 1 Inflammatory Bowel Diseases 1 Gastritis, Atrophic 1 Crohn Disease 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1 Carcinoma, Transitional Cell 1 Cancer Care Recipient 1 Cancer Awareness and Prevention Education 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Arthritis, Reactive 1 Arthritis, Psoriatic 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4 Palliative Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Educational Status × Clear all

NCT06117592 2024-02-21

CASCADE

The Christie NHS Foundation Trust

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡